PL2349220T3 - Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny - Google Patents

Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny

Info

Publication number: PL2349220T3
Authority: PL; Poland
Prior art keywords: moxifloxacin; organic solvents; wet granulation; granulation; wet
Prior art date: 2008-10-09

Application number

PL08807939T

Other languages

English (en)

Inventor

Farhad Farshi

Recep Avci

Fikret Koc

Serdar Soylemez

Original Assignee

Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-09

Filing date

2008-10-09

Publication date

2012-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40070762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2349220(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-09 Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi

2012-12-31 Publication of PL2349220T3 publication Critical patent/PL2349220T3/pl

Links

FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 title 1
229960003702 moxifloxacin Drugs 0.000 title 1
239000003960 organic solvent Substances 0.000 title 1
238000005550 wet granulation Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL08807939T 2008-10-09 2008-10-09 Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny PL2349220T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08807939A EP2349220B1 (en)	2008-10-09	2008-10-09	Using of organic solvents in wet granulation of moxifloxacin
PCT/IB2008/054141 WO2010041100A1 (en)	2008-10-09	2008-10-09	Using of organic solvents in wet granulation of moxifloxacin

Publications (1)

Publication Number	Publication Date
PL2349220T3 true PL2349220T3 (pl)	2012-12-31

Family

ID=40070762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08807939T PL2349220T3 (pl)	2008-10-09	2008-10-09	Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny

Country Status (12)

Country	Link
US (1)	US8314122B2 (pl)
EP (1)	EP2349220B1 (pl)
JP (1)	JP5461565B2 (pl)
CN (1)	CN102176902B (pl)
BR (1)	BRPI0823092A2 (pl)
EA (1)	EA201170545A1 (pl)
ES (1)	ES2391132T3 (pl)
MX (1)	MX2011003731A (pl)
PL (1)	PL2349220T3 (pl)
PT (1)	PT2349220E (pl)
TR (1)	TR201106844T2 (pl)
WO (1)	WO2010041100A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200907227A2 (tr) *	2009-09-18	2011-04-21	Bi̇lgi̇ç Mahmut	Çözünürlüğü yüksek stabil mikronize granüller.
EP2491921A1 (en) *	2011-02-25	2012-08-29	Deva Holding Anonim Sirketi	Conservation of anhydrous form of gemifloxacin
CN102204911B (zh) *	2011-03-25	2013-04-17	华润赛科药业有限责任公司	一种盐酸莫西沙星药物组合物及其制备方法
BRPI1106900A2 (pt) *	2011-12-26	2013-11-05	Ems Sa	Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr)	2012-06-22	2015-01-23	Rivopharm Sa	Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
IL315294A (en) *	2015-03-03	2024-10-01	Pharmacyclics Llc	Pharmaceutical formulations of proton tyrosine kinase inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3906365A1 (de)	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0782449B1 (en) *	1994-09-22	2003-04-09	Akzo Nobel N.V.	Process of making dosage units by wet granulation
DE19546249A1 (de)	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
BRPI9915208B8 (pt) *	1998-11-10	2021-07-06	Bayer Ag	preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
US20060252789A1 (en) *	2002-10-31	2006-11-09	Sujay Biswas	Amorphous moxifloxacin hydrochloride
GB0301259D0 (en) *	2003-01-20	2003-02-19	Novartis Ag	Organic compounds
EP2113505A1 (en) *	2003-04-09	2009-11-04	Dr. Reddy's Laboratories, Ltd.	A crystalline form III of anhydrous moxifloxacin hydrochloride and processes for the preparation thereof
US20050031683A1 (en) *	2003-08-04	2005-02-10	Ashish Kapoor	Solid pharmaceutical composition
DE102005036195A1 (de)	2005-08-02	2007-02-08	Robert Bosch Gmbh	Handwerkzeugmaschine
GB0612422D0 (en) *	2006-06-23	2006-08-02	Generics Uk Ltd	Novel hydrate form

2008
- 2008-10-09 PL PL08807939T patent/PL2349220T3/pl unknown
- 2008-10-09 MX MX2011003731A patent/MX2011003731A/es not_active Application Discontinuation
- 2008-10-09 ES ES08807939T patent/ES2391132T3/es active Active
- 2008-10-09 EP EP08807939A patent/EP2349220B1/en not_active Revoked
- 2008-10-09 TR TR2011/06844T patent/TR201106844T2/xx unknown
- 2008-10-09 CN CN200880131455XA patent/CN102176902B/zh not_active Expired - Fee Related
- 2008-10-09 PT PT08807939T patent/PT2349220E/pt unknown
- 2008-10-09 JP JP2011530582A patent/JP5461565B2/ja not_active Expired - Fee Related
- 2008-10-09 BR BRPI0823092A patent/BRPI0823092A2/pt not_active IP Right Cessation
- 2008-10-09 EA EA201170545A patent/EA201170545A1/ru unknown
- 2008-10-09 WO PCT/IB2008/054141 patent/WO2010041100A1/en not_active Ceased
- 2008-10-09 US US13/122,935 patent/US8314122B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP5461565B2 (ja)	2014-04-02
TR201106844T2 (tr)	2012-02-21
PT2349220E (pt)	2012-10-11
US20110198774A1 (en)	2011-08-18
MX2011003731A (es)	2011-08-03
EP2349220A1 (en)	2011-08-03
BRPI0823092A2 (pt)	2015-09-29
EA201170545A1 (ru)	2012-01-30
CN102176902A (zh)	2011-09-07
JP2012505194A (ja)	2012-03-01
ES2391132T3 (es)	2012-11-21
CN102176902B (zh)	2012-10-31
EP2349220B1 (en)	2012-07-25
WO2010041100A1 (en)	2010-04-15
US8314122B2 (en)	2012-11-20

Publication	Publication Date	Title
IL246600B (en)	2018-10-31	Heterocyclic compounds and their use
BRPI0912026A2 (pt)	2015-10-06	formulação homeopática
ZA201006505B (en)	2011-05-25	Novel heterocyclic compounds and uses thereof
IL218078A0 (en)	2012-04-30	Heterocyclic compounds and uses thereof
ZA201104104B (en)	2012-08-29	Improved solvent removal
ZA201101123B (en)	2012-04-25	Nicotine-containing granulate
EP2637669A4 (en)	2014-04-02	Heterocyclic compounds and their use
EP2376408A4 (en)	2012-06-20	FLUORATION OF ORGANIC COMPOUNDS
DK2376490T3 (da)	2013-04-15	Imidazopyridinforbindelser
IL208601A0 (en)	2010-12-30	Dried formulations
GB2491797B (en)	2016-03-30	Low layer solvent extractor
ZA201008262B (en)	2011-07-27	Heterocyclic compounds
EP2262426A4 (en)	2014-08-06	VEHICULAR SOLVENT FOR DYKLOSCOPIC FORMULATIONS
GB0822323D0 (en)	2009-01-14	Drying aid composition
GB0822633D0 (en)	2009-01-21	Formulation
EP2325379A4 (en)	2013-01-02	DRYING DEVICE OF TYPE CONDENSATION
GB0811455D0 (en)	2008-07-30	Improvements in & relating to solvent processing
GB0800788D0 (en)	2008-02-27	Niovel formulation
GB201001895D0 (en)	2010-03-24	Improvements relating to drying apparatus
GB0814376D0 (en)	2008-09-10	Formulation
GB0821360D0 (en)	2008-12-31	Solvent
GB0822020D0 (en)	2009-01-07	Uses of clenbuterol
GB0802827D0 (en)	2008-03-26	Purely bodies
IL208925A0 (en)	2011-01-31	Stable benzimidazole formulation
HK1147753A (zh)	2011-08-19	新杂环化合物及其用途